Bispecific antibodies for the treatment of tumours and infectious diseases

Author： Drakeman D.L.   Fanger M.W.   Wallace P.K.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.6, Iss.9, 1997-09, pp. : 1169-1178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liposomes in the treatment of infectious diseases

By Fielding R.   Lasic D.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 12, 1999-12 ,pp. : 1679-1688

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal antibodies for prophylaxis and therapy of infectious diseases

By Meulen Jan ter  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 4, 2007-11 ,pp. : 525-540

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases

By  

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4498-4507

Bentham Science Publishers

Access to resources Recommend Favorite

Infectious Complications Associated With Immunomodulating Monoclonal Antibodies Used in the Treatment of Hematologic Malignancy

By Koo Sophia   Baden Lindsey R.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 2, 2008-02 ,pp. : 202-213

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Generation of Bispecific Antibodies by Fc Heterodimerization and their Application

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 15, 2016-12 ,pp. : 1324-1332

Bentham Science Publishers

Access to resources Recommend Favorite